Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2019English

The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies

Blood Cancer Journal
OncologyHematology
2011English

Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I

Acta Crystallographica Section A: Foundations and Advances
Materials ScienceCondensed Matter PhysicsTheoretical ChemistryBiochemistryStructural BiologyInorganic ChemistryPhysical
2014English

CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon

Clinical Cancer Research
Cancer ResearchOncology
2015English

Mechanism of Analgesic Action of Y-23023, a New Non-Steroidal Anti-Inflammatory Drug.

Folia Pharmacologica Japonica
Pharmacology
1995English

Monovalent Antibody Design and Mechanism of Action of Onartuzumab, a MET Antagonist With Anti-Tumor Activity as a Therapeutic Agent

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy